Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer. (Q40134862)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Consequences of the loss of p53, RB1, and PTEN: relationship to gefitinib resistance in endometrial cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Lina Albitar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Mark B Carter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Suzy Davies

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

8 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

94-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

The molecular biology of endometrial adenocarcinoma

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Progesterone receptor isoform identification and subcellular localization in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Clinicoprognostic significance of pRb1 pathway alterations in uterine endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Uterine papillary serous carcinoma evolves via a p53-driven pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

New developments in the multi-site phosphorylation and integration of stress signalling at p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Multisite phosphorylation and the integration of stress signals at p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Review of epidermal growth factor receptor biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Epidermal growth factor induces rapid tyrosine phosphorylation of proteins in A431 human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Autophosphorylation sites on the epidermal growth factor receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Differential expression of the A and B isoforms of progesterone receptor in human endometrial cancer cells. Only progesterone receptor B is induced by estrogen and associated with strong transcriptional activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Progesterone regulation of activating protein-1 transcriptional activity: a possible mechanism of progesterone inhibition of endometrial cancer cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Identification of a novel mechanism of NF-kappaB inactivation by progesterone through progesterone receptors in Hec50co poorly differentiated endometrial cancer cells: induction of A20 and ABIN-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

JNK targets p53 ubiquitination and degradation in nonstressed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Cooperation between p53 and p130(Rb2) in induction of cellular senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

The Ishikawa Cells from Birth to the Present

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Mdm2 association with p53 targets its ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Molecular interaction map of the mammalian cell cycle control and DNA repair systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

RAS and RHO GTPases in G1-phase cell-cycle regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Cdc25 phosphatases and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

MMP-1: the elder of the family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

P53 down-regulates matrix metalloproteinase-1 by targeting the communications between AP-1 and the basal transcription complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Surviving the kiss of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Mechanisms of cell necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Targeting apoptosis pathways in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

p53-independent pRB degradation contributes to a drug-induced apoptosis in AGS cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

Endometrial cancer chemoprevention: implications of diverse pathways of carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.006

10.1016/J.YGYNO.2007.03.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17490733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference